Skip to main content
Erschienen in: Virchows Archiv 3/2015

01.03.2015 | Original Article

miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma

verfasst von: Tuukka Veija, Helka Sahi, Virve Koljonen, Tom Bohling, Sakari Knuutila, Neda Mosakhani

Erschienen in: Virchows Archiv | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Merkel cell polyomavirus (MCV) is frequently detectable in Merkel cell carcinoma (MCC) tumors, but the significance of MCV infection is not yet totally understood. Thus far, no key regulatory miRNA has been identified for MCC tumorigenesis. However, distinct miRNA expression profiles have been suggested for MCV-positive and MCV-negative tumors. We used microarray hybridization to identify miRNA expression differences in MCC tumor samples according to MCV status and further validated these results by quantitative reverse transcription polymerase chain reaction (qRT-PCR). When compared with MCV-negative tumors, we detected overexpression of miR-34a, miR-30a, miR-142-3p, and miR-1539 in those MCV positives. In addition, slight underexpression was detectable in MCV-positive tumors of miR-181d. We confirmed the distinct expression of miRNAs in MCV-positive and MCV-negative tumors and confirmed statistically significant underexpression of miR-34a in MCV-negative tumors by both array analysis and qRT-PCR. Neither tumor location nor development of metastases affected miRNA expression.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945CrossRefPubMed Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945CrossRefPubMed
3.
Zurück zum Zitat Kassem A, Technau K, Kurz AK, Pantulu D, Loning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, Zur Hausen A (2009) Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 125:356–361CrossRefPubMed Kassem A, Technau K, Kurz AK, Pantulu D, Loning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, Zur Hausen A (2009) Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 125:356–361CrossRefPubMed
4.
Zurück zum Zitat Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272–16277CrossRefPubMedCentralPubMed Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272–16277CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Kukko H, Bohling T, Koljonen V, Tukiainen E, Haglund C, Pokhrel A, Sankila R, Pukkala E (2012) Merkel cell carcinoma—a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer 48:737–742CrossRefPubMed Kukko H, Bohling T, Koljonen V, Tukiainen E, Haglund C, Pokhrel A, Sankila R, Pukkala E (2012) Merkel cell carcinoma—a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer 48:737–742CrossRefPubMed
6.
Zurück zum Zitat Koljonen V, Kukko H, Pukkala E, Sankila R, Bohling T, Tukiainen E, Sihto H, Joensuu H (2009) Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 101:1444–1447CrossRefPubMedCentralPubMed Koljonen V, Kukko H, Pukkala E, Sankila R, Bohling T, Tukiainen E, Sihto H, Joensuu H (2009) Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 101:1444–1447CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Koljonen V, Kukko H, Tukiainen E, Bohling T, Sankila R, Pukkala E, Sihto H, Joensuu H, Kyllonen L, Makisalo H (2009) Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 24:3231–3235CrossRefPubMed Koljonen V, Kukko H, Tukiainen E, Bohling T, Sankila R, Pukkala E, Sihto H, Joensuu H, Kyllonen L, Makisalo H (2009) Incidence of Merkel cell carcinoma in renal transplant recipients. Nephrol Dial Transplant 24:3231–3235CrossRefPubMed
8.
Zurück zum Zitat Cardoso JC, Teixeira V, Tchernev G, Wollina U (2013) Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. Wien Med Wochenschr. doi:10.1007/s10354-013-0218-0 Cardoso JC, Teixeira V, Tchernev G, Wollina U (2013) Merkel cell carcinoma: a review and update on aetiopathogenesis, diagnosis and treatment approaches. Wien Med Wochenschr. doi:10.​1007/​s10354-013-0218-0
9.
Zurück zum Zitat Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK (2013) Distinct gene expression profiles of viral- and nonviral-associated Merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 133:936–945CrossRefPubMedCentralPubMed Harms PW, Patel RM, Verhaegen ME, Giordano TJ, Nash KT, Johnson CN, Daignault S, Thomas DG, Gudjonsson JE, Elder JT, Dlugosz AA, Johnson TM, Fullen DR, Bichakjian CK (2013) Distinct gene expression profiles of viral- and nonviral-associated Merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 133:936–945CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Higaki-Mori H, Kuwamoto S, Iwasaki T, Kato M, Murakami I, Nagata K, Sano H, Horie Y, Yoshida Y, Yamamoto O, Adachi K, Nanba E, Hayashi K (2012) Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 43:2282–2291CrossRefPubMed Higaki-Mori H, Kuwamoto S, Iwasaki T, Kato M, Murakami I, Nagata K, Sano H, Horie Y, Yoshida Y, Yamamoto O, Adachi K, Nanba E, Hayashi K (2012) Association of Merkel cell polyomavirus infection with clinicopathological differences in Merkel cell carcinoma. Hum Pathol 43:2282–2291CrossRefPubMed
12.
Zurück zum Zitat Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer 126:2240–2246PubMedCentralPubMed Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer 126:2240–2246PubMedCentralPubMed
13.
Zurück zum Zitat Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer 127:1493–1496CrossRefPubMedCentralPubMed Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer 127:1493–1496CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17:4806–4813CrossRefPubMed Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17:4806–4813CrossRefPubMed
15.
Zurück zum Zitat Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMed Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297CrossRefPubMed
16.
18.
Zurück zum Zitat Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundstrom J, Ristamaki R, Osterlund P, Knuutila S (2012) MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosome Cancer 51:1–9CrossRef Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundstrom J, Ristamaki R, Osterlund P, Knuutila S (2012) MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosome Cancer 51:1–9CrossRef
19.
Zurück zum Zitat Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y (2009) Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125:1243–1249CrossRefPubMed Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernandez-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y (2009) Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer 125:1243–1249CrossRefPubMed
20.
Zurück zum Zitat Loyo M, Guerrero-Preston R, Brait M, Hoque MO, Chuang A, Kim MS, Sharma R, Liegeois NJ, Koch WM, Califano JA, Westra WH, Sidransky D (2010) Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 126:2991–2996PubMedCentralPubMed Loyo M, Guerrero-Preston R, Brait M, Hoque MO, Chuang A, Kim MS, Sharma R, Liegeois NJ, Koch WM, Califano JA, Westra WH, Sidransky D (2010) Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer 126:2991–2996PubMedCentralPubMed
21.
Zurück zum Zitat Foulongne V, Kluger N, Dereure O, Mercier G, Moles JP, Guillot B, Segondy M (2010) Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis 16:685–687CrossRefPubMedCentralPubMed Foulongne V, Kluger N, Dereure O, Mercier G, Moles JP, Guillot B, Segondy M (2010) Merkel cell polyomavirus in cutaneous swabs. Emerg Infect Dis 16:685–687CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Rodig SJ, Cheng J, Wardzala J, DoRosario A, Scanlon JJ, Laga AC, Martinez-Fernandez A, Barletta JA, Bellizzi AM, Sadasivam S, Holloway DT, Cooper DJ, Kupper TS, Wang LC, DeCaprio JA (2012) Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 122:4645–4653. doi:10.1172/JCI64116; 10.1172/JCI64116 Rodig SJ, Cheng J, Wardzala J, DoRosario A, Scanlon JJ, Laga AC, Martinez-Fernandez A, Barletta JA, Bellizzi AM, Sadasivam S, Holloway DT, Cooper DJ, Kupper TS, Wang LC, DeCaprio JA (2012) Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest 122:4645–4653. doi:10.​1172/​JCI64116; 10.​1172/​JCI64116
23.
Zurück zum Zitat Waltari M, Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma. Int J Cancer 129:619–628CrossRefPubMed Waltari M, Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma. Int J Cancer 129:619–628CrossRefPubMed
24.
Zurück zum Zitat Paulson KG, Lemos BD, Feng B, Jaimes N, Penas PF, Bi X, Maher E, Cohen L, Leonard JH, Granter SR, Chin L, Nghiem P (2009) Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol 129:1547–1555CrossRefPubMed Paulson KG, Lemos BD, Feng B, Jaimes N, Penas PF, Bi X, Maher E, Cohen L, Leonard JH, Granter SR, Chin L, Nghiem P (2009) Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol 129:1547–1555CrossRefPubMed
25.
Zurück zum Zitat He L, He X, Lowe SW, Hannon GJ (2007) microRNAs join the p53 network—another piece in the tumour-suppression puzzle. Nat Rev Cancer 7:819–822CrossRefPubMedCentralPubMed He L, He X, Lowe SW, Hannon GJ (2007) microRNAs join the p53 network—another piece in the tumour-suppression puzzle. Nat Rev Cancer 7:819–822CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Yamakuchi M, Lowenstein CJ (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8:712–715CrossRefPubMed Yamakuchi M, Lowenstein CJ (2009) MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 8:712–715CrossRefPubMed
28.
Zurück zum Zitat Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15:637–647. doi:10.1261/rna.1442309; 10.1261/rna.1442309 Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15:637–647. doi:10.​1261/​rna.​1442309; 10.​1261/​rna.​1442309
29.
Zurück zum Zitat Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43–50CrossRefPubMedCentralPubMed Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43–50CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731–743CrossRefPubMed Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26:731–743CrossRefPubMed
33.
Zurück zum Zitat Yang F, Li QJ, Gong ZB, Zhou L, You N, Wang S, Li XL, Li JJ, An JZ, Wang DS, He Y, Dou KF (2013) MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Technol Cancer Res Treat. doi:10.7785/tcrt.2012.500364 Yang F, Li QJ, Gong ZB, Zhou L, You N, Wang S, Li XL, Li JJ, An JZ, Wang DS, He Y, Dou KF (2013) MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment. Technol Cancer Res Treat. doi:10.​7785/​tcrt.​2012.​500364
Metadaten
Titel
miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma
verfasst von
Tuukka Veija
Helka Sahi
Virve Koljonen
Tom Bohling
Sakari Knuutila
Neda Mosakhani
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2015
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-014-1700-9

Weitere Artikel der Ausgabe 3/2015

Virchows Archiv 3/2015 Zur Ausgabe

Editorial

In this issue

Neu im Fachgebiet Pathologie